Rachel Frank
Concepts (851)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Arthroscopy | 58 | 2025 | 244 | 9.730 |
Why?
| | Shoulder Joint | 50 | 2024 | 176 | 9.310 |
Why?
| | Joint Instability | 36 | 2024 | 170 | 8.690 |
Why?
| | Anterior Cruciate Ligament Reconstruction | 20 | 2026 | 153 | 5.720 |
Why?
| | Cartilage, Articular | 23 | 2026 | 340 | 4.920 |
Why?
| | Anterior Cruciate Ligament Injuries | 20 | 2026 | 172 | 4.750 |
Why?
| | Knee Joint | 30 | 2026 | 414 | 4.610 |
Why?
| | Knee Injuries | 18 | 2022 | 102 | 4.530 |
Why?
| | Sports Medicine | 12 | 2026 | 114 | 4.520 |
Why?
| | Tibial Meniscus Injuries | 12 | 2025 | 50 | 4.440 |
Why?
| | Shoulder Dislocation | 17 | 2026 | 53 | 4.260 |
Why?
| | Biological Products | 12 | 2024 | 252 | 4.250 |
Why?
| | Orthopedic Procedures | 19 | 2021 | 233 | 4.170 |
Why?
| | Tibia | 14 | 2025 | 189 | 4.110 |
Why?
| | Menisci, Tibial | 17 | 2025 | 63 | 3.960 |
Why?
| | Athletic Injuries | 23 | 2026 | 551 | 3.890 |
Why?
| | Orthopedics | 13 | 2026 | 160 | 3.880 |
Why?
| | Bone Transplantation | 14 | 2025 | 86 | 3.430 |
Why?
| | Osteotomy | 12 | 2025 | 126 | 3.260 |
Why?
| | Platelet-Rich Plasma | 13 | 2025 | 37 | 3.150 |
Why?
| | Osteoarthritis, Knee | 18 | 2026 | 274 | 3.070 |
Why?
| | Femoracetabular Impingement | 8 | 2018 | 35 | 2.840 |
Why?
| | Simulation Training | 6 | 2024 | 133 | 2.790 |
Why?
| | Rotator Cuff Injuries | 12 | 2026 | 64 | 2.690 |
Why?
| | Tenodesis | 8 | 2020 | 19 | 2.280 |
Why?
| | Hip Joint | 8 | 2018 | 180 | 2.280 |
Why?
| | Cartilage Diseases | 5 | 2019 | 45 | 2.240 |
Why?
| | Arthroplasty, Replacement, Knee | 9 | 2025 | 370 | 2.190 |
Why?
| | Arthroplasty | 10 | 2020 | 57 | 2.170 |
Why?
| | Reoperation | 29 | 2023 | 602 | 2.170 |
Why?
| | Meniscus | 4 | 2023 | 23 | 2.050 |
Why?
| | Allografts | 19 | 2025 | 151 | 1.970 |
Why?
| | Humans | 310 | 2026 | 143817 | 1.960 |
Why?
| | Shoulder Injuries | 9 | 2024 | 59 | 1.910 |
Why?
| | Tendons | 11 | 2026 | 128 | 1.740 |
Why?
| | Shoulder | 22 | 2023 | 93 | 1.720 |
Why?
| | Arthroplasty, Replacement, Shoulder | 9 | 2020 | 34 | 1.670 |
Why?
| | Postoperative Complications | 25 | 2026 | 2894 | 1.660 |
Why?
| | Return to Sport | 10 | 2025 | 111 | 1.660 |
Why?
| | Cartilage | 10 | 2025 | 195 | 1.630 |
Why?
| | Transplantation, Homologous | 19 | 2025 | 414 | 1.620 |
Why?
| | Computer Simulation | 6 | 2021 | 1032 | 1.610 |
Why?
| | Sports | 7 | 2023 | 213 | 1.580 |
Why?
| | Patient Reported Outcome Measures | 11 | 2026 | 464 | 1.530 |
Why?
| | Suture Anchors | 7 | 2021 | 32 | 1.480 |
Why?
| | Musculoskeletal Diseases | 5 | 2024 | 88 | 1.470 |
Why?
| | Clinical Competence | 8 | 2024 | 1226 | 1.450 |
Why?
| | Athletes | 7 | 2023 | 413 | 1.440 |
Why?
| | Scapula | 11 | 2023 | 44 | 1.440 |
Why?
| | Internship and Residency | 9 | 2026 | 1245 | 1.440 |
Why?
| | Acromioclavicular Joint | 3 | 2023 | 11 | 1.430 |
Why?
| | Tendon Injuries | 5 | 2019 | 67 | 1.350 |
Why?
| | Adult | 131 | 2026 | 40128 | 1.280 |
Why?
| | Young Adult | 52 | 2026 | 13914 | 1.190 |
Why?
| | Second-Look Surgery | 3 | 2025 | 7 | 1.180 |
Why?
| | Femur | 9 | 2025 | 271 | 1.160 |
Why?
| | Male | 165 | 2026 | 71568 | 1.130 |
Why?
| | Treatment Outcome | 50 | 2025 | 11459 | 1.120 |
Why?
| | Humeral Head | 7 | 2023 | 15 | 1.100 |
Why?
| | Evidence-Based Medicine | 7 | 2020 | 711 | 1.090 |
Why?
| | Female | 160 | 2026 | 77569 | 1.090 |
Why?
| | Bankart Lesions | 4 | 2023 | 9 | 1.070 |
Why?
| | Arthroplasty, Subchondral | 4 | 2018 | 7 | 1.060 |
Why?
| | Rotator Cuff | 8 | 2023 | 47 | 1.040 |
Why?
| | Anterior Cruciate Ligament | 9 | 2023 | 80 | 1.030 |
Why?
| | Quadriceps Muscle | 3 | 2026 | 117 | 1.030 |
Why?
| | Middle Aged | 106 | 2026 | 35629 | 1.010 |
Why?
| | Bone Malalignment | 2 | 2025 | 13 | 0.990 |
Why?
| | Bone Screws | 5 | 2020 | 108 | 0.990 |
Why?
| | Biomechanical Phenomena | 17 | 2025 | 870 | 0.980 |
Why?
| | Female Athlete Triad Syndrome | 2 | 2017 | 3 | 0.980 |
Why?
| | Joint Dislocations | 2 | 2024 | 56 | 0.980 |
Why?
| | Ligaments, Articular | 5 | 2023 | 52 | 0.970 |
Why?
| | Hemiarthroplasty | 3 | 2020 | 9 | 0.940 |
Why?
| | Education, Medical, Graduate | 5 | 2019 | 548 | 0.940 |
Why?
| | Osteoarthritis | 7 | 2019 | 193 | 0.920 |
Why?
| | Range of Motion, Articular | 17 | 2023 | 415 | 0.920 |
Why?
| | Orthopedic Surgeons | 2 | 2023 | 28 | 0.890 |
Why?
| | Achilles Tendon | 2 | 2023 | 34 | 0.860 |
Why?
| | Follow-Up Studies | 37 | 2021 | 5317 | 0.840 |
Why?
| | Blood Loss, Surgical | 2 | 2014 | 112 | 0.810 |
Why?
| | Adolescent | 77 | 2025 | 22233 | 0.800 |
Why?
| | Cadaver | 13 | 2020 | 301 | 0.800 |
Why?
| | Social Media | 2 | 2024 | 168 | 0.750 |
Why?
| | Brain Concussion | 5 | 2025 | 633 | 0.730 |
Why?
| | Venous Thrombosis | 2 | 2022 | 194 | 0.720 |
Why?
| | Retrospective Studies | 57 | 2025 | 16755 | 0.710 |
Why?
| | Lacerations | 1 | 2022 | 40 | 0.710 |
Why?
| | Pain | 6 | 2018 | 776 | 0.700 |
Why?
| | Arthroplasty, Replacement, Hip | 2 | 2014 | 187 | 0.700 |
Why?
| | Golf | 1 | 2020 | 8 | 0.650 |
Why?
| | Bone Resorption | 3 | 2018 | 85 | 0.650 |
Why?
| | Rupture | 8 | 2023 | 86 | 0.640 |
Why?
| | Hypertension | 12 | 2025 | 1239 | 0.640 |
Why?
| | Skiing | 1 | 2021 | 49 | 0.640 |
Why?
| | Radiography | 16 | 2019 | 838 | 0.640 |
Why?
| | Suture Techniques | 8 | 2019 | 126 | 0.620 |
Why?
| | Hamstring Muscles | 2 | 2018 | 21 | 0.610 |
Why?
| | Physical Examination | 9 | 2018 | 235 | 0.590 |
Why?
| | Internet | 3 | 2022 | 699 | 0.590 |
Why?
| | Aged | 72 | 2025 | 25616 | 0.590 |
Why?
| | Humerus | 7 | 2020 | 40 | 0.590 |
Why?
| | Stress, Mechanical | 4 | 2026 | 499 | 0.560 |
Why?
| | Kidney Transplantation | 6 | 2024 | 693 | 0.560 |
Why?
| | Swimming | 1 | 2018 | 49 | 0.550 |
Why?
| | Prosthesis Failure | 5 | 2015 | 125 | 0.550 |
Why?
| | Tenotomy | 1 | 2018 | 22 | 0.550 |
Why?
| | Virtual Reality | 1 | 2019 | 75 | 0.540 |
Why?
| | Yoga | 1 | 2018 | 30 | 0.540 |
Why?
| | Glenoid Cavity | 2 | 2015 | 8 | 0.530 |
Why?
| | Carcinoma, Renal Cell | 4 | 2019 | 233 | 0.530 |
Why?
| | Adipose Tissue | 6 | 2025 | 656 | 0.530 |
Why?
| | Meniscectomy | 3 | 2025 | 16 | 0.530 |
Why?
| | Leg Injuries | 1 | 2017 | 24 | 0.530 |
Why?
| | Treatment Failure | 6 | 2020 | 363 | 0.530 |
Why?
| | Facial Recognition | 1 | 2018 | 35 | 0.530 |
Why?
| | Venous Thromboembolism | 1 | 2022 | 330 | 0.520 |
Why?
| | Bone Density | 2 | 2021 | 501 | 0.520 |
Why?
| | Facial Expression | 1 | 2018 | 74 | 0.520 |
Why?
| | Fractures, Stress | 1 | 2017 | 29 | 0.520 |
Why?
| | Imaging, Three-Dimensional | 4 | 2018 | 577 | 0.520 |
Why?
| | Olecranon Process | 1 | 2017 | 7 | 0.510 |
Why?
| | Bundle of His | 1 | 2017 | 19 | 0.510 |
Why?
| | Fractures, Ununited | 1 | 2017 | 26 | 0.500 |
Why?
| | Prosthesis-Related Infections | 2 | 2015 | 99 | 0.500 |
Why?
| | Cumulative Trauma Disorders | 1 | 2017 | 31 | 0.500 |
Why?
| | Transplantation, Autologous | 7 | 2026 | 290 | 0.500 |
Why?
| | Ulna Fractures | 1 | 2017 | 16 | 0.500 |
Why?
| | Open Fracture Reduction | 1 | 2017 | 31 | 0.500 |
Why?
| | Bicycling | 1 | 2017 | 120 | 0.500 |
Why?
| | Social Perception | 1 | 2018 | 107 | 0.500 |
Why?
| | Injections, Intra-Articular | 9 | 2025 | 57 | 0.500 |
Why?
| | Mesenchymal Stem Cell Transplantation | 3 | 2025 | 59 | 0.500 |
Why?
| | Hip | 3 | 2014 | 57 | 0.500 |
Why?
| | Muscle, Skeletal | 8 | 2020 | 1807 | 0.500 |
Why?
| | Atrioventricular Block | 1 | 2017 | 45 | 0.490 |
Why?
| | Chondrocytes | 2 | 2018 | 231 | 0.490 |
Why?
| | Databases, Factual | 10 | 2019 | 1459 | 0.490 |
Why?
| | Osteosarcoma | 2 | 2015 | 77 | 0.470 |
Why?
| | Sex Factors | 8 | 2026 | 2078 | 0.470 |
Why?
| | Incidence | 13 | 2025 | 2845 | 0.470 |
Why?
| | Ozone | 4 | 2001 | 133 | 0.470 |
Why?
| | Kidney Neoplasms | 4 | 2019 | 410 | 0.470 |
Why?
| | Soft Tissue Injuries | 1 | 2016 | 33 | 0.460 |
Why?
| | Patellar Ligament | 2 | 2014 | 25 | 0.460 |
Why?
| | Risk Factors | 25 | 2025 | 10623 | 0.460 |
Why?
| | Stereotyping | 1 | 2015 | 46 | 0.450 |
Why?
| | Electrocardiography | 5 | 2017 | 635 | 0.450 |
Why?
| | Prejudice | 1 | 2015 | 60 | 0.440 |
Why?
| | Comprehension | 2 | 2014 | 181 | 0.440 |
Why?
| | Bone-Patellar Tendon-Bone Grafts | 1 | 2014 | 2 | 0.440 |
Why?
| | Blood Pressure Monitoring, Ambulatory | 5 | 2023 | 67 | 0.440 |
Why?
| | Transcatheter Aortic Valve Replacement | 1 | 2017 | 141 | 0.440 |
Why?
| | Cohort Studies | 14 | 2023 | 5862 | 0.430 |
Why?
| | Ilium | 1 | 2014 | 30 | 0.430 |
Why?
| | Child | 52 | 2025 | 22441 | 0.430 |
Why?
| | Arthroplasty, Replacement | 5 | 2016 | 47 | 0.430 |
Why?
| | Fracture Fixation, Internal | 1 | 2017 | 206 | 0.420 |
Why?
| | Hip Injuries | 1 | 2014 | 14 | 0.420 |
Why?
| | Blood Pressure | 9 | 2025 | 1751 | 0.420 |
Why?
| | Patient Education as Topic | 4 | 2024 | 791 | 0.420 |
Why?
| | Patellofemoral Joint | 2 | 2023 | 8 | 0.410 |
Why?
| | Image Processing, Computer-Assisted | 4 | 2014 | 787 | 0.410 |
Why?
| | Hip Prosthesis | 1 | 2014 | 46 | 0.400 |
Why?
| | Retroperitoneal Neoplasms | 2 | 2013 | 28 | 0.400 |
Why?
| | Materials Testing | 2 | 2017 | 358 | 0.400 |
Why?
| | Patient Satisfaction | 3 | 2018 | 700 | 0.400 |
Why?
| | Models, Educational | 1 | 2013 | 88 | 0.390 |
Why?
| | Computer-Assisted Instruction | 1 | 2013 | 71 | 0.390 |
Why?
| | Graft Survival | 6 | 2019 | 510 | 0.390 |
Why?
| | Body Mass Index | 6 | 2025 | 2439 | 0.390 |
Why?
| | Delphi Technique | 9 | 2025 | 324 | 0.390 |
Why?
| | Emotions | 2 | 2018 | 575 | 0.390 |
Why?
| | Bone and Bones | 1 | 2016 | 322 | 0.380 |
Why?
| | Time-to-Treatment | 1 | 2015 | 235 | 0.380 |
Why?
| | Models, Anatomic | 1 | 2013 | 84 | 0.380 |
Why?
| | Recurrence | 15 | 2023 | 1122 | 0.380 |
Why?
| | Liposarcoma | 1 | 2013 | 31 | 0.380 |
Why?
| | Education, Medical, Continuing | 1 | 2013 | 130 | 0.380 |
Why?
| | Postoperative Period | 8 | 2019 | 353 | 0.370 |
Why?
| | Pain Measurement | 9 | 2025 | 550 | 0.370 |
Why?
| | Neoplasms, Multiple Primary | 1 | 2013 | 57 | 0.370 |
Why?
| | Femur Neck | 1 | 2012 | 63 | 0.370 |
Why?
| | Femur Head | 1 | 2012 | 41 | 0.370 |
Why?
| | Pain Management | 2 | 2014 | 399 | 0.370 |
Why?
| | Magnetic Resonance Imaging | 7 | 2026 | 3834 | 0.370 |
Why?
| | Acetabulum | 2 | 2014 | 110 | 0.370 |
Why?
| | Autism Spectrum Disorder | 1 | 2018 | 431 | 0.370 |
Why?
| | Nephrectomy | 2 | 2013 | 156 | 0.370 |
Why?
| | Surveys and Questionnaires | 10 | 2026 | 6004 | 0.360 |
Why?
| | Universities | 1 | 2014 | 452 | 0.360 |
Why?
| | Musculoskeletal System | 2 | 2022 | 48 | 0.350 |
Why?
| | Rotation | 3 | 2018 | 119 | 0.340 |
Why?
| | Hyaluronic Acid | 7 | 2025 | 210 | 0.340 |
Why?
| | Age Factors | 11 | 2019 | 3288 | 0.330 |
Why?
| | Nephrotic Syndrome | 4 | 2022 | 43 | 0.330 |
Why?
| | Tomography, X-Ray Computed | 9 | 2020 | 2782 | 0.330 |
Why?
| | Physical Therapy Modalities | 4 | 2026 | 328 | 0.320 |
Why?
| | Activities of Daily Living | 4 | 2018 | 435 | 0.320 |
Why?
| | Football | 3 | 2017 | 86 | 0.310 |
Why?
| | United States | 22 | 2025 | 15602 | 0.310 |
Why?
| | Practice Patterns, Physicians' | 4 | 2026 | 1322 | 0.310 |
Why?
| | Stem Cell Transplantation | 3 | 2020 | 190 | 0.310 |
Why?
| | Health Care Surveys | 3 | 2017 | 535 | 0.300 |
Why?
| | Random Allocation | 4 | 2019 | 364 | 0.300 |
Why?
| | Joint Prosthesis | 3 | 2015 | 22 | 0.300 |
Why?
| | Aged, 80 and over | 22 | 2021 | 8130 | 0.300 |
Why?
| | Reproducibility of Results | 9 | 2024 | 3392 | 0.300 |
Why?
| | Pilot Projects | 7 | 2021 | 1851 | 0.290 |
Why?
| | Hypertrophy, Left Ventricular | 3 | 2023 | 120 | 0.290 |
Why?
| | Patient Readmission | 3 | 2018 | 724 | 0.260 |
Why?
| | Mass Screening | 2 | 2014 | 1325 | 0.260 |
Why?
| | Joint Diseases | 3 | 2019 | 62 | 0.250 |
Why?
| | Nephrology | 2 | 2024 | 60 | 0.250 |
Why?
| | Glomerulosclerosis, Focal Segmental | 4 | 2016 | 43 | 0.250 |
Why?
| | Ambulatory Surgical Procedures | 2 | 2017 | 75 | 0.240 |
Why?
| | Attitude of Health Personnel | 2 | 2026 | 1174 | 0.240 |
Why?
| | Arthralgia | 2 | 2025 | 58 | 0.240 |
Why?
| | Risk Assessment | 9 | 2025 | 3556 | 0.240 |
Why?
| | Patient Positioning | 2 | 2019 | 71 | 0.240 |
Why?
| | Infant Mortality | 2 | 2004 | 123 | 0.240 |
Why?
| | Synovectomy | 1 | 2025 | 8 | 0.240 |
Why?
| | Matched-Pair Analysis | 2 | 2016 | 37 | 0.230 |
Why?
| | Synovitis | 1 | 2025 | 33 | 0.230 |
Why?
| | Video Recording | 2 | 2024 | 209 | 0.230 |
Why?
| | Recovery of Function | 8 | 2026 | 695 | 0.230 |
Why?
| | Electrocoagulation | 4 | 2014 | 34 | 0.230 |
Why?
| | Operative Time | 1 | 2026 | 178 | 0.230 |
Why?
| | Head Injuries, Closed | 1 | 2025 | 50 | 0.230 |
Why?
| | Time Factors | 19 | 2019 | 7068 | 0.220 |
Why?
| | Pulmonary Embolism | 3 | 2018 | 238 | 0.220 |
Why?
| | Soccer | 1 | 2025 | 36 | 0.220 |
Why?
| | Respiratory Mechanics | 2 | 1995 | 74 | 0.220 |
Why?
| | Complement Activation | 2 | 2025 | 411 | 0.220 |
Why?
| | Humeral Fractures | 2 | 2017 | 46 | 0.220 |
Why?
| | Wound Healing | 3 | 2013 | 361 | 0.220 |
Why?
| | Tachycardia, Ventricular | 4 | 2000 | 177 | 0.220 |
Why?
| | Viscosupplements | 3 | 2020 | 11 | 0.220 |
Why?
| | Autografts | 3 | 2026 | 51 | 0.210 |
Why?
| | Complement Factor H | 1 | 2025 | 79 | 0.210 |
Why?
| | Reading | 3 | 2014 | 134 | 0.210 |
Why?
| | Clinical Trials as Topic | 2 | 2020 | 1047 | 0.210 |
Why?
| | Catheter Ablation | 5 | 2000 | 351 | 0.210 |
Why?
| | Caffeine | 1 | 2024 | 72 | 0.210 |
Why?
| | Synovial Membrane | 1 | 2025 | 123 | 0.210 |
Why?
| | Patellar Dislocation | 1 | 2023 | 7 | 0.210 |
Why?
| | Consensus | 5 | 2025 | 480 | 0.210 |
Why?
| | Curriculum | 2 | 2021 | 1044 | 0.200 |
Why?
| | Bone Marrow | 3 | 2023 | 303 | 0.200 |
Why?
| | Prognosis | 13 | 2020 | 4211 | 0.200 |
Why?
| | Prehypertension | 1 | 2023 | 27 | 0.200 |
Why?
| | Prospective Studies | 10 | 2023 | 7900 | 0.200 |
Why?
| | Heart Ventricles | 5 | 2019 | 754 | 0.200 |
Why?
| | Cross-Sectional Studies | 10 | 2026 | 5761 | 0.190 |
Why?
| | Sutures | 3 | 2019 | 63 | 0.190 |
Why?
| | Urolithiasis | 2 | 2016 | 10 | 0.190 |
Why?
| | Muscle Strength | 1 | 2026 | 336 | 0.190 |
Why?
| | Ankle Injuries | 1 | 2023 | 64 | 0.190 |
Why?
| | Debridement | 4 | 2017 | 88 | 0.190 |
Why?
| | Postoperative Care | 4 | 2019 | 278 | 0.180 |
Why?
| | Research Design | 2 | 2018 | 1121 | 0.180 |
Why?
| | Intra-Articular Fractures | 2 | 2019 | 19 | 0.180 |
Why?
| | Oxidants, Photochemical | 1 | 2001 | 8 | 0.180 |
Why?
| | Cardiovascular Diseases | 2 | 2024 | 2098 | 0.170 |
Why?
| | Urinary Diversion | 2 | 1998 | 13 | 0.170 |
Why?
| | Preoperative Period | 2 | 2018 | 145 | 0.170 |
Why?
| | Osteoarthritis, Hip | 1 | 2021 | 47 | 0.170 |
Why?
| | Knee Dislocation | 1 | 2021 | 7 | 0.170 |
Why?
| | Biology | 1 | 2022 | 91 | 0.170 |
Why?
| | Arm | 2 | 2019 | 109 | 0.170 |
Why?
| | Verbal Learning | 2 | 2007 | 72 | 0.170 |
Why?
| | Drug Chronotherapy | 1 | 2020 | 1 | 0.170 |
Why?
| | Ankle | 2 | 2019 | 64 | 0.170 |
Why?
| | Comorbidity | 5 | 2018 | 1638 | 0.170 |
Why?
| | Operating Rooms | 2 | 2024 | 145 | 0.160 |
Why?
| | Arthritis, Rheumatoid | 4 | 2025 | 1170 | 0.160 |
Why?
| | Socioeconomic Factors | 2 | 2004 | 1327 | 0.160 |
Why?
| | Randomized Controlled Trials as Topic | 4 | 2025 | 1688 | 0.160 |
Why?
| | Antihypertensive Agents | 2 | 2020 | 500 | 0.160 |
Why?
| | Arrhythmogenic Right Ventricular Dysplasia | 1 | 2000 | 60 | 0.160 |
Why?
| | Echocardiography | 4 | 2020 | 642 | 0.160 |
Why?
| | Marketing of Health Services | 1 | 2020 | 15 | 0.160 |
Why?
| | Direct-to-Consumer Advertising | 1 | 2020 | 8 | 0.160 |
Why?
| | Delayed Graft Function | 2 | 2018 | 37 | 0.160 |
Why?
| | Osteonecrosis | 1 | 2020 | 23 | 0.160 |
Why?
| | Absorptiometry, Photon | 1 | 2021 | 277 | 0.150 |
Why?
| | Multiple Trauma | 1 | 2021 | 118 | 0.150 |
Why?
| | Kidney | 7 | 2016 | 1483 | 0.150 |
Why?
| | Algorithms | 3 | 2023 | 1843 | 0.150 |
Why?
| | Spinal Neoplasms | 1 | 2019 | 36 | 0.150 |
Why?
| | Intraoperative Complications | 2 | 2012 | 155 | 0.150 |
Why?
| | Bone Substitutes | 1 | 2019 | 27 | 0.150 |
Why?
| | Case-Control Studies | 4 | 2026 | 3614 | 0.150 |
Why?
| | Kidney Diseases | 3 | 2024 | 418 | 0.150 |
Why?
| | Artificial Intelligence | 1 | 2023 | 360 | 0.150 |
Why?
| | Workers' Compensation | 1 | 2019 | 27 | 0.140 |
Why?
| | Tensile Strength | 1 | 2019 | 98 | 0.140 |
Why?
| | Graft Rejection | 3 | 2018 | 536 | 0.140 |
Why?
| | Pudendal Nerve | 1 | 2018 | 2 | 0.140 |
Why?
| | Surgeons | 1 | 2023 | 336 | 0.140 |
Why?
| | Shoulder Impingement Syndrome | 2 | 2018 | 7 | 0.140 |
Why?
| | Acromion | 2 | 2017 | 8 | 0.140 |
Why?
| | Odds Ratio | 2 | 2018 | 1057 | 0.140 |
Why?
| | Visual Analog Scale | 1 | 2018 | 34 | 0.140 |
Why?
| | Osteochondritis Dissecans | 1 | 2018 | 11 | 0.140 |
Why?
| | Immunosuppressive Agents | 3 | 2008 | 843 | 0.140 |
Why?
| | Thinness | 1 | 2018 | 99 | 0.140 |
Why?
| | Mycophenolic Acid | 3 | 2008 | 120 | 0.140 |
Why?
| | Prosthesis Design | 3 | 2015 | 354 | 0.130 |
Why?
| | Urinary Bladder Diseases | 1 | 1998 | 18 | 0.130 |
Why?
| | Radius | 1 | 2018 | 52 | 0.130 |
Why?
| | Arthrography | 1 | 2017 | 18 | 0.130 |
Why?
| | Spine | 1 | 2019 | 181 | 0.130 |
Why?
| | Bone Marrow Transplantation | 1 | 2019 | 294 | 0.130 |
Why?
| | Ambulatory Care Facilities | 1 | 2020 | 260 | 0.130 |
Why?
| | Child, Preschool | 19 | 2025 | 11631 | 0.130 |
Why?
| | Sleep Wake Disorders | 1 | 2021 | 312 | 0.130 |
Why?
| | Hospital Charges | 1 | 2017 | 45 | 0.130 |
Why?
| | Obesity | 2 | 2018 | 3073 | 0.130 |
Why?
| | Surgical Wound Infection | 3 | 2018 | 327 | 0.130 |
Why?
| | Length of Stay | 3 | 2018 | 1312 | 0.130 |
Why?
| | Multiple Sclerosis | 3 | 2008 | 482 | 0.130 |
Why?
| | Nephrons | 1 | 2016 | 22 | 0.130 |
Why?
| | Bronchi | 2 | 1996 | 270 | 0.130 |
Why?
| | Hypercalciuria | 1 | 2016 | 2 | 0.130 |
Why?
| | Anticoagulants | 1 | 2022 | 718 | 0.120 |
Why?
| | Orthopedic Fixation Devices | 1 | 2016 | 8 | 0.120 |
Why?
| | Shoulder Fractures | 1 | 2016 | 15 | 0.120 |
Why?
| | Patient Safety | 1 | 2020 | 338 | 0.120 |
Why?
| | Medical History Taking | 2 | 2014 | 113 | 0.120 |
Why?
| | Fever | 2 | 2017 | 311 | 0.120 |
Why?
| | Dementia | 1 | 2000 | 296 | 0.120 |
Why?
| | Emergency Medical Services | 1 | 2023 | 685 | 0.120 |
Why?
| | Elbow Joint | 1 | 2016 | 74 | 0.120 |
Why?
| | Image Interpretation, Computer-Assisted | 1 | 2018 | 285 | 0.120 |
Why?
| | Minimally Invasive Surgical Procedures | 3 | 2014 | 191 | 0.110 |
Why?
| | Glomerular Filtration Rate | 6 | 2020 | 751 | 0.110 |
Why?
| | Femoral Neck Fractures | 1 | 2015 | 21 | 0.110 |
Why?
| | Diagnosis, Differential | 4 | 2018 | 1502 | 0.110 |
Why?
| | Femoral Neoplasms | 1 | 2015 | 10 | 0.110 |
Why?
| | Tendinopathy | 1 | 2015 | 29 | 0.110 |
Why?
| | Lung Diseases | 2 | 2001 | 794 | 0.110 |
Why?
| | Kidney Failure, Chronic | 3 | 2018 | 596 | 0.110 |
Why?
| | Bone-Patellar Tendon-Bone Grafting | 1 | 2014 | 11 | 0.110 |
Why?
| | Limb Salvage | 1 | 2015 | 71 | 0.110 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2018 | 342 | 0.110 |
Why?
| | Ontario | 3 | 2023 | 94 | 0.110 |
Why?
| | Hemodilution | 1 | 2014 | 11 | 0.110 |
Why?
| | Journal Impact Factor | 1 | 2014 | 28 | 0.110 |
Why?
| | Immobilization | 2 | 2026 | 51 | 0.110 |
Why?
| | Fracture Fixation | 1 | 2015 | 81 | 0.110 |
Why?
| | Menstrual Cycle | 1 | 1995 | 140 | 0.110 |
Why?
| | Arthritis | 2 | 2016 | 95 | 0.110 |
Why?
| | Tachycardia | 4 | 1989 | 57 | 0.110 |
Why?
| | Hemostasis, Surgical | 1 | 2014 | 27 | 0.110 |
Why?
| | Spinal Stenosis | 1 | 2014 | 30 | 0.110 |
Why?
| | Military Personnel | 2 | 2020 | 694 | 0.100 |
Why?
| | Tourniquets | 1 | 2014 | 34 | 0.100 |
Why?
| | Running | 1 | 2016 | 232 | 0.100 |
Why?
| | Intervertebral Disc Displacement | 1 | 2014 | 40 | 0.100 |
Why?
| | Professional Practice | 1 | 2014 | 58 | 0.100 |
Why?
| | Diagnostic Imaging | 2 | 2014 | 334 | 0.100 |
Why?
| | Prostheses and Implants | 1 | 2015 | 141 | 0.100 |
Why?
| | Referral and Consultation | 3 | 2012 | 839 | 0.100 |
Why?
| | Hemostatics | 1 | 2014 | 60 | 0.100 |
Why?
| | Malnutrition | 1 | 2015 | 84 | 0.100 |
Why?
| | Electromyography | 1 | 2016 | 415 | 0.100 |
Why?
| | Pressure | 1 | 2014 | 230 | 0.100 |
Why?
| | Laser Coagulation | 1 | 2014 | 76 | 0.100 |
Why?
| | Prosthesis Implantation | 1 | 2015 | 155 | 0.100 |
Why?
| | Nutrition Surveys | 2 | 2025 | 279 | 0.100 |
Why?
| | Blood Component Transfusion | 1 | 2014 | 103 | 0.100 |
Why?
| | Adrenal Cortex Hormones | 2 | 2015 | 500 | 0.100 |
Why?
| | Arrhythmias, Cardiac | 5 | 2001 | 351 | 0.100 |
Why?
| | Canada | 1 | 2014 | 425 | 0.100 |
Why?
| | Learning Curve | 1 | 2013 | 72 | 0.100 |
Why?
| | Circadian Rhythm | 2 | 2016 | 516 | 0.100 |
Why?
| | Athletic Performance | 1 | 2014 | 76 | 0.100 |
Why?
| | Patient Selection | 3 | 2025 | 695 | 0.100 |
Why?
| | Societies, Medical | 2 | 2014 | 865 | 0.100 |
Why?
| | Health Status Disparities | 1 | 2016 | 315 | 0.100 |
Why?
| | Metals | 1 | 2014 | 143 | 0.100 |
Why?
| | Gait | 1 | 2016 | 324 | 0.090 |
Why?
| | Multivariate Analysis | 5 | 2017 | 1508 | 0.090 |
Why?
| | Spirometry | 3 | 2001 | 264 | 0.090 |
Why?
| | Arthrometry, Articular | 1 | 2012 | 8 | 0.090 |
Why?
| | Incidental Findings | 1 | 2013 | 80 | 0.090 |
Why?
| | Popliteal Vein | 1 | 2012 | 4 | 0.090 |
Why?
| | Pneumonia | 1 | 2018 | 641 | 0.090 |
Why?
| | Watchful Waiting | 1 | 2012 | 86 | 0.090 |
Why?
| | Posterior Cruciate Ligament | 1 | 2012 | 13 | 0.090 |
Why?
| | Nutritional Status | 1 | 2015 | 351 | 0.090 |
Why?
| | Ultrasonography | 3 | 2022 | 766 | 0.090 |
Why?
| | Severity of Illness Index | 6 | 2016 | 2925 | 0.090 |
Why?
| | Locomotion | 1 | 2012 | 103 | 0.090 |
Why?
| | Periodicals as Topic | 1 | 2014 | 201 | 0.090 |
Why?
| | Pandemics | 1 | 2020 | 1675 | 0.090 |
Why?
| | Circumcision, Male | 1 | 2011 | 16 | 0.090 |
Why?
| | Registries | 2 | 2018 | 2242 | 0.090 |
Why?
| | Popliteal Artery | 1 | 2012 | 61 | 0.090 |
Why?
| | Osseointegration | 1 | 2012 | 71 | 0.090 |
Why?
| | Prednisone | 3 | 2007 | 223 | 0.090 |
Why?
| | Diagnostic Errors | 1 | 2012 | 176 | 0.090 |
Why?
| | Educational Measurement | 1 | 2014 | 322 | 0.090 |
Why?
| | Policy Making | 1 | 2011 | 82 | 0.080 |
Why?
| | Smoking | 1 | 2018 | 1556 | 0.080 |
Why?
| | Proteinuria | 3 | 2007 | 102 | 0.080 |
Why?
| | Sexual Behavior | 1 | 2015 | 490 | 0.080 |
Why?
| | Tooth | 2 | 1990 | 45 | 0.080 |
Why?
| | Disability Evaluation | 1 | 2012 | 306 | 0.080 |
Why?
| | Interleukin-7 | 1 | 2010 | 65 | 0.080 |
Why?
| | Ankle Joint | 2 | 2023 | 119 | 0.080 |
Why?
| | Reference Standards | 1 | 2010 | 181 | 0.080 |
Why?
| | Preventive Health Services | 1 | 2011 | 152 | 0.080 |
Why?
| | Bicuspid | 2 | 1988 | 14 | 0.080 |
Why?
| | Lead | 1 | 1990 | 70 | 0.080 |
Why?
| | Upper Extremity | 1 | 2010 | 111 | 0.080 |
Why?
| | Molar | 2 | 1988 | 48 | 0.070 |
Why?
| | Cancer Vaccines | 1 | 2010 | 167 | 0.070 |
Why?
| | Biopsy, Needle | 1 | 2009 | 184 | 0.070 |
Why?
| | Transplant Recipients | 2 | 2022 | 180 | 0.070 |
Why?
| | Naturopathy | 1 | 2008 | 2 | 0.070 |
Why?
| | Fractures, Bone | 1 | 2014 | 416 | 0.070 |
Why?
| | Pesticide Residues | 1 | 1988 | 4 | 0.070 |
Why?
| | Sepsis | 1 | 2015 | 639 | 0.070 |
Why?
| | Vascular Surgical Procedures | 1 | 2012 | 343 | 0.070 |
Why?
| | Transillumination | 1 | 1988 | 3 | 0.070 |
Why?
| | Mexico | 2 | 2004 | 231 | 0.070 |
Why?
| | Urologic Diseases | 1 | 2008 | 39 | 0.070 |
Why?
| | Urography | 2 | 1998 | 19 | 0.070 |
Why?
| | Rheumatoid Factor | 3 | 2025 | 175 | 0.070 |
Why?
| | Insecticides | 1 | 1988 | 42 | 0.070 |
Why?
| | Quality Improvement | 1 | 2016 | 1268 | 0.070 |
Why?
| | Glomerulonephritis, Membranous | 1 | 2007 | 2 | 0.070 |
Why?
| | Heart Arrest | 2 | 2012 | 403 | 0.070 |
Why?
| | Neuropsychological Tests | 2 | 2019 | 1122 | 0.070 |
Why?
| | Systole | 2 | 2019 | 173 | 0.070 |
Why?
| | Leptospira interrogans | 2 | 1985 | 4 | 0.070 |
Why?
| | Diagnostic Tests, Routine | 1 | 2008 | 110 | 0.070 |
Why?
| | Ginkgo biloba | 1 | 2007 | 10 | 0.060 |
Why?
| | Dental Caries | 2 | 1988 | 173 | 0.060 |
Why?
| | Creatinine | 3 | 2008 | 492 | 0.060 |
Why?
| | Hospitalization | 3 | 2016 | 2340 | 0.060 |
Why?
| | Logistic Models | 3 | 2015 | 2095 | 0.060 |
Why?
| | HLA-DR Antigens | 2 | 1997 | 219 | 0.060 |
Why?
| | Lysholm Knee Score | 2 | 2016 | 8 | 0.060 |
Why?
| | Reagent Strips | 1 | 2006 | 8 | 0.060 |
Why?
| | Milk, Human | 1 | 1988 | 171 | 0.060 |
Why?
| | Bronchoalveolar Lavage Fluid | 2 | 2001 | 644 | 0.060 |
Why?
| | Depressive Disorder | 2 | 2006 | 367 | 0.060 |
Why?
| | Minimal Clinically Important Difference | 1 | 2025 | 27 | 0.060 |
Why?
| | Urine | 1 | 2006 | 62 | 0.060 |
Why?
| | Dental Enamel | 3 | 1990 | 68 | 0.060 |
Why?
| | Fatigue | 1 | 2008 | 356 | 0.060 |
Why?
| | Atmosphere Exposure Chambers | 2 | 1995 | 7 | 0.060 |
Why?
| | Nephrosis, Lipoid | 1 | 2005 | 11 | 0.060 |
Why?
| | Ligaments | 2 | 2020 | 78 | 0.060 |
Why?
| | Plant Extracts | 1 | 2007 | 194 | 0.060 |
Why?
| | Return to Work | 2 | 2015 | 19 | 0.060 |
Why?
| | Hyperparathyroidism | 1 | 2004 | 11 | 0.050 |
Why?
| | Shoulder Pain | 2 | 2018 | 32 | 0.050 |
Why?
| | Sleep | 2 | 2022 | 903 | 0.050 |
Why?
| | History, 21st Century | 1 | 2025 | 222 | 0.050 |
Why?
| | Lung | 2 | 1995 | 4143 | 0.050 |
Why?
| | Leukocytes | 1 | 2006 | 293 | 0.050 |
Why?
| | Regression Analysis | 4 | 2016 | 1003 | 0.050 |
Why?
| | Probability | 2 | 2006 | 305 | 0.050 |
Why?
| | Maternal Age | 1 | 2004 | 127 | 0.050 |
Why?
| | Vital Capacity | 2 | 1995 | 311 | 0.050 |
Why?
| | Weil Disease | 1 | 1983 | 1 | 0.050 |
Why?
| | Acidosis, Renal Tubular | 1 | 2003 | 4 | 0.050 |
Why?
| | Joint Capsule | 2 | 2016 | 10 | 0.050 |
Why?
| | Peripheral Nerve Injuries | 2 | 2017 | 38 | 0.050 |
Why?
| | Parathyroid Hormone | 1 | 2004 | 112 | 0.050 |
Why?
| | Failure to Thrive | 1 | 2003 | 28 | 0.050 |
Why?
| | Cognition Disorders | 1 | 2008 | 542 | 0.050 |
Why?
| | Radionuclide Angiography | 2 | 2001 | 3 | 0.050 |
Why?
| | Health Status | 2 | 2008 | 821 | 0.050 |
Why?
| | Bicarbonates | 1 | 2003 | 45 | 0.050 |
Why?
| | Forced Expiratory Volume | 2 | 1995 | 493 | 0.050 |
Why?
| | Social Justice | 1 | 2004 | 85 | 0.050 |
Why?
| | Felodipine | 1 | 2003 | 3 | 0.050 |
Why?
| | New England | 1 | 2003 | 36 | 0.050 |
Why?
| | Vesico-Ureteral Reflux | 1 | 2003 | 38 | 0.050 |
Why?
| | Linear Models | 2 | 2016 | 857 | 0.050 |
Why?
| | Blood Chemical Analysis | 1 | 2003 | 110 | 0.050 |
Why?
| | Antibodies, Bacterial | 1 | 1983 | 147 | 0.050 |
Why?
| | Urinalysis | 2 | 2016 | 81 | 0.050 |
Why?
| | Injections | 1 | 2023 | 194 | 0.050 |
Why?
| | Evaluation Studies as Topic | 3 | 1998 | 169 | 0.050 |
Why?
| | Leukocyte Count | 1 | 2023 | 317 | 0.050 |
Why?
| | Dyslipidemias | 1 | 2024 | 170 | 0.050 |
Why?
| | Tissue Scaffolds | 1 | 2025 | 221 | 0.050 |
Why?
| | Receptors, Cholecystokinin | 1 | 2002 | 9 | 0.050 |
Why?
| | Indoleacetic Acids | 1 | 2002 | 10 | 0.050 |
Why?
| | Hormone Antagonists | 1 | 2002 | 34 | 0.050 |
Why?
| | Tomography, Emission-Computed | 1 | 2002 | 70 | 0.050 |
Why?
| | Nephritis, Hereditary | 1 | 2002 | 3 | 0.050 |
Why?
| | American Heart Association | 1 | 2023 | 301 | 0.050 |
Why?
| | Enalapril | 1 | 2002 | 16 | 0.050 |
Why?
| | Environmental Exposure | 2 | 2001 | 584 | 0.050 |
Why?
| | Emergencies | 1 | 2023 | 172 | 0.050 |
Why?
| | Infant | 8 | 2013 | 9886 | 0.040 |
Why?
| | Thiazoles | 1 | 2002 | 134 | 0.040 |
Why?
| | Forecasting | 1 | 2023 | 388 | 0.040 |
Why?
| | Nitrites | 1 | 2002 | 89 | 0.040 |
Why?
| | Vaccines, Conjugate | 1 | 2002 | 60 | 0.040 |
Why?
| | Airway Resistance | 1 | 2001 | 38 | 0.040 |
Why?
| | Radiopharmaceuticals | 1 | 2002 | 191 | 0.040 |
Why?
| | Analysis of Variance | 4 | 2011 | 1308 | 0.040 |
Why?
| | Meningococcal Vaccines | 1 | 2002 | 58 | 0.040 |
Why?
| | Fluorodeoxyglucose F18 | 1 | 2002 | 153 | 0.040 |
Why?
| | Confidence Intervals | 2 | 2016 | 330 | 0.040 |
Why?
| | Weight-Bearing | 2 | 2013 | 180 | 0.040 |
Why?
| | Exercise Therapy | 1 | 2026 | 465 | 0.040 |
Why?
| | Dentin | 2 | 1990 | 22 | 0.040 |
Why?
| | Sensitivity and Specificity | 3 | 2018 | 1984 | 0.040 |
Why?
| | Albuminuria | 1 | 2002 | 187 | 0.040 |
Why?
| | Urinary Tract Infections | 1 | 2003 | 201 | 0.040 |
Why?
| | Respiration | 1 | 2001 | 209 | 0.040 |
Why?
| | Angiotensin-Converting Enzyme Inhibitors | 1 | 2002 | 193 | 0.040 |
Why?
| | Pneumococcal Vaccines | 1 | 2002 | 129 | 0.040 |
Why?
| | Bartter Syndrome | 1 | 2000 | 7 | 0.040 |
Why?
| | Heart Function Tests | 1 | 2000 | 55 | 0.040 |
Why?
| | Antibiotic Prophylaxis | 1 | 2002 | 128 | 0.040 |
Why?
| | Heart Diseases | 1 | 2004 | 343 | 0.040 |
Why?
| | Poverty | 1 | 2004 | 522 | 0.040 |
Why?
| | Renal Artery Obstruction | 1 | 2000 | 29 | 0.040 |
Why?
| | Mental Status Schedule | 1 | 2000 | 34 | 0.040 |
Why?
| | Language Tests | 1 | 2000 | 23 | 0.040 |
Why?
| | Renal Artery | 1 | 2000 | 43 | 0.040 |
Why?
| | Reference Values | 3 | 2000 | 806 | 0.040 |
Why?
| | Consumer Product Safety | 1 | 2020 | 32 | 0.040 |
Why?
| | Cognition | 2 | 2007 | 1252 | 0.040 |
Why?
| | Hematopoietic Stem Cell Mobilization | 1 | 1999 | 27 | 0.040 |
Why?
| | Predictive Value of Tests | 3 | 2001 | 2097 | 0.040 |
Why?
| | Polycystic Kidney, Autosomal Dominant | 1 | 2003 | 235 | 0.040 |
Why?
| | Bacterial Infections | 1 | 2002 | 247 | 0.040 |
Why?
| | HIV Infections | 2 | 2011 | 3048 | 0.040 |
Why?
| | Aggrecans | 1 | 2019 | 15 | 0.040 |
Why?
| | Seizures | 1 | 2023 | 454 | 0.040 |
Why?
| | Pediatrics | 2 | 2024 | 1080 | 0.040 |
Why?
| | Vitamin E | 1 | 1999 | 117 | 0.040 |
Why?
| | Transforming Growth Factor beta | 1 | 2002 | 481 | 0.040 |
Why?
| | Survival Rate | 2 | 2001 | 2035 | 0.040 |
Why?
| | Elective Surgical Procedures | 1 | 2020 | 196 | 0.040 |
Why?
| | Chronic Traumatic Encephalopathy | 1 | 2019 | 17 | 0.040 |
Why?
| | Quality of Life | 2 | 2015 | 3141 | 0.040 |
Why?
| | Diastole | 1 | 2019 | 141 | 0.040 |
Why?
| | United Kingdom | 1 | 2020 | 332 | 0.040 |
Why?
| | Proteoglycans | 1 | 2019 | 109 | 0.040 |
Why?
| | Urinary Bladder | 2 | 1998 | 191 | 0.040 |
Why?
| | Serum | 1 | 2019 | 58 | 0.040 |
Why?
| | Lymphoma, Non-Hodgkin | 1 | 1999 | 124 | 0.040 |
Why?
| | Research Subjects | 1 | 2018 | 43 | 0.040 |
Why?
| | Calcium | 1 | 2004 | 1181 | 0.040 |
Why?
| | Depression | 1 | 2008 | 1520 | 0.040 |
Why?
| | Ventricular Dysfunction, Right | 1 | 2001 | 245 | 0.030 |
Why?
| | Thigh | 1 | 2018 | 48 | 0.030 |
Why?
| | Deltoid Muscle | 1 | 2017 | 6 | 0.030 |
Why?
| | Benzophenones | 1 | 2017 | 16 | 0.030 |
Why?
| | ROC Curve | 1 | 2000 | 607 | 0.030 |
Why?
| | Cystoscopy | 1 | 1998 | 20 | 0.030 |
Why?
| | Pectoralis Muscles | 1 | 2017 | 19 | 0.030 |
Why?
| | Radiographic Image Enhancement | 1 | 1998 | 59 | 0.030 |
Why?
| | Sciatic Nerve | 1 | 2018 | 63 | 0.030 |
Why?
| | Demography | 1 | 2018 | 289 | 0.030 |
Why?
| | Anatomic Landmarks | 1 | 2017 | 31 | 0.030 |
Why?
| | Dissection | 1 | 2018 | 55 | 0.030 |
Why?
| | HLA-DP Antigens | 1 | 1997 | 32 | 0.030 |
Why?
| | Torque | 1 | 2017 | 81 | 0.030 |
Why?
| | Brachial Plexus | 1 | 2017 | 35 | 0.030 |
Why?
| | Biomarkers | 3 | 2019 | 4248 | 0.030 |
Why?
| | Ketones | 1 | 2017 | 52 | 0.030 |
Why?
| | White Coat Hypertension | 1 | 2016 | 4 | 0.030 |
Why?
| | Proportional Hazards Models | 1 | 2000 | 1305 | 0.030 |
Why?
| | RNA, Messenger | 1 | 2025 | 2847 | 0.030 |
Why?
| | Tarsal Bones | 1 | 2016 | 14 | 0.030 |
Why?
| | HLA-DQ Antigens | 1 | 1997 | 173 | 0.030 |
Why?
| | User-Computer Interface | 1 | 1998 | 164 | 0.030 |
Why?
| | Glucose | 1 | 2002 | 1041 | 0.030 |
Why?
| | Adaptation, Psychological | 1 | 2022 | 705 | 0.030 |
Why?
| | Guidelines as Topic | 1 | 2019 | 270 | 0.030 |
Why?
| | Respiratory Function Tests | 2 | 1996 | 570 | 0.030 |
Why?
| | Neuroimaging | 1 | 2019 | 286 | 0.030 |
Why?
| | Hominidae | 1 | 1997 | 87 | 0.030 |
Why?
| | Inspiratory Capacity | 1 | 1996 | 3 | 0.030 |
Why?
| | Chronic Disease | 1 | 2022 | 1826 | 0.030 |
Why?
| | Tissue Donors | 1 | 2019 | 413 | 0.030 |
Why?
| | Frontal Lobe | 1 | 1997 | 159 | 0.030 |
Why?
| | Insulin Resistance | 1 | 2024 | 1255 | 0.030 |
Why?
| | Antioxidants | 1 | 1999 | 580 | 0.030 |
Why?
| | Lung Volume Measurements | 1 | 1995 | 46 | 0.030 |
Why?
| | Blood Pressure Determination | 1 | 2016 | 141 | 0.030 |
Why?
| | Hemodynamics | 1 | 2000 | 1116 | 0.030 |
Why?
| | Synovitis, Pigmented Villonodular | 1 | 2015 | 3 | 0.030 |
Why?
| | Maximal Midexpiratory Flow Rate | 1 | 1995 | 5 | 0.030 |
Why?
| | Endoscopy | 1 | 1998 | 326 | 0.030 |
Why?
| | Ossification, Heterotopic | 1 | 2015 | 18 | 0.030 |
Why?
| | Blood Glucose | 1 | 2025 | 2325 | 0.030 |
Why?
| | Hypertrophy, Right Ventricular | 1 | 1995 | 149 | 0.030 |
Why?
| | Contraindications | 1 | 2015 | 84 | 0.030 |
Why?
| | Pulmonary Ventilation | 1 | 1995 | 84 | 0.030 |
Why?
| | Adenocarcinoma | 1 | 2002 | 927 | 0.030 |
Why?
| | Capillary Permeability | 1 | 1995 | 136 | 0.030 |
Why?
| | Infant, Newborn | 2 | 2004 | 6362 | 0.030 |
Why?
| | Dental Pulp | 1 | 1974 | 4 | 0.030 |
Why?
| | Decision Making | 2 | 2011 | 966 | 0.030 |
Why?
| | Remission, Spontaneous | 1 | 2014 | 40 | 0.030 |
Why?
| | Essential Hypertension | 1 | 2014 | 3 | 0.030 |
Why?
| | Radiotherapy Dosage | 1 | 2015 | 283 | 0.030 |
Why?
| | Nutrition Assessment | 1 | 2015 | 92 | 0.030 |
Why?
| | Bronchoscopy | 1 | 1995 | 227 | 0.030 |
Why?
| | Cardiomyopathy, Hypertrophic | 1 | 1995 | 145 | 0.030 |
Why?
| | Wolff-Parkinson-White Syndrome | 1 | 1994 | 19 | 0.030 |
Why?
| | Periodontitis | 1 | 1974 | 53 | 0.030 |
Why?
| | Radiographic Image Interpretation, Computer-Assisted | 1 | 2015 | 121 | 0.030 |
Why?
| | Insurance, Health | 2 | 2014 | 296 | 0.030 |
Why?
| | Private Practice | 1 | 2014 | 19 | 0.030 |
Why?
| | Bibliometrics | 1 | 2014 | 58 | 0.030 |
Why?
| | Guided Tissue Regeneration | 1 | 2013 | 13 | 0.030 |
Why?
| | Urban Population | 2 | 1990 | 485 | 0.030 |
Why?
| | Pancreatic Neoplasms | 1 | 2002 | 927 | 0.030 |
Why?
| | Educational Status | 2 | 2013 | 463 | 0.030 |
Why?
| | Biopsy | 3 | 2007 | 1068 | 0.030 |
Why?
| | Pregnancy | 2 | 2004 | 7154 | 0.030 |
Why?
| | Polymers | 1 | 2017 | 500 | 0.030 |
Why?
| | Outpatients | 1 | 2017 | 431 | 0.030 |
Why?
| | Caregivers | 1 | 2022 | 1025 | 0.020 |
Why?
| | Penile Diseases | 1 | 1993 | 5 | 0.020 |
Why?
| | Histoplasmosis | 1 | 1993 | 15 | 0.020 |
Why?
| | Electric Stimulation Therapy | 1 | 1994 | 80 | 0.020 |
Why?
| | Acute Disease | 3 | 2015 | 996 | 0.020 |
Why?
| | Wounds, Penetrating | 1 | 1994 | 73 | 0.020 |
Why?
| | Exercise | 2 | 1995 | 2196 | 0.020 |
Why?
| | Skull | 1 | 1994 | 154 | 0.020 |
Why?
| | Academies and Institutes | 1 | 2013 | 61 | 0.020 |
Why?
| | Survival Analysis | 1 | 2016 | 1358 | 0.020 |
Why?
| | Biological Evolution | 1 | 1997 | 489 | 0.020 |
Why?
| | Cervical Vertebrae | 1 | 2014 | 157 | 0.020 |
Why?
| | Inpatients | 1 | 2017 | 528 | 0.020 |
Why?
| | Polyethylene Glycols | 1 | 2017 | 638 | 0.020 |
Why?
| | Pulmonary Edema | 2 | 2012 | 106 | 0.020 |
Why?
| | France | 2 | 1990 | 39 | 0.020 |
Why?
| | Inflammation Mediators | 1 | 1995 | 511 | 0.020 |
Why?
| | Exercise Test | 1 | 1995 | 621 | 0.020 |
Why?
| | Bone Neoplasms | 1 | 2015 | 251 | 0.020 |
Why?
| | Sarcoma | 1 | 2015 | 203 | 0.020 |
Why?
| | North America | 1 | 2013 | 309 | 0.020 |
Why?
| | Sterilization | 1 | 2012 | 24 | 0.020 |
Why?
| | Drug Therapy, Combination | 1 | 2015 | 1032 | 0.020 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2013 | 382 | 0.020 |
Why?
| | Personal Health Services | 1 | 1991 | 1 | 0.020 |
Why?
| | Practice Guidelines as Topic | 1 | 2020 | 1525 | 0.020 |
Why?
| | Papua New Guinea | 1 | 2011 | 11 | 0.020 |
Why?
| | Intestinal Obstruction | 2 | 1991 | 56 | 0.020 |
Why?
| | Gamma Rays | 1 | 2012 | 58 | 0.020 |
Why?
| | Health Planning Guidelines | 1 | 2011 | 24 | 0.020 |
Why?
| | Medicare | 1 | 2017 | 821 | 0.020 |
Why?
| | Temporomandibular Joint | 1 | 1991 | 8 | 0.020 |
Why?
| | Denture, Complete | 1 | 1991 | 7 | 0.020 |
Why?
| | Mouth, Edentulous | 1 | 1991 | 10 | 0.020 |
Why?
| | Dentition | 1 | 1991 | 15 | 0.020 |
Why?
| | World Health Organization | 1 | 2011 | 103 | 0.020 |
Why?
| | Joint Capsule Release | 1 | 2011 | 2 | 0.020 |
Why?
| | Prefrontal Cortex | 1 | 1994 | 326 | 0.020 |
Why?
| | Rhabdomyosarcoma | 1 | 1991 | 63 | 0.020 |
Why?
| | Mental Disorders | 1 | 2000 | 1127 | 0.020 |
Why?
| | Animals | 6 | 2019 | 38140 | 0.020 |
Why?
| | B7-1 Antigen | 1 | 2010 | 55 | 0.020 |
Why?
| | Health Literacy | 1 | 2013 | 180 | 0.020 |
Why?
| | Rabbits | 1 | 2012 | 656 | 0.020 |
Why?
| | Retinoids | 1 | 1990 | 33 | 0.020 |
Why?
| | Epidemiologic Methods | 2 | 1988 | 92 | 0.020 |
Why?
| | Hospital Mortality | 1 | 2015 | 975 | 0.020 |
Why?
| | Guanylate Cyclase | 1 | 1990 | 39 | 0.020 |
Why?
| | Polyethylene | 1 | 2010 | 17 | 0.020 |
Why?
| | Intestine, Small | 1 | 1991 | 166 | 0.020 |
Why?
| | Models, Animal | 1 | 2012 | 394 | 0.020 |
Why?
| | Bone Diseases | 1 | 1990 | 65 | 0.020 |
Why?
| | Substance Abuse, Intravenous | 1 | 1991 | 124 | 0.020 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 1999 | 1938 | 0.020 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2024 | 2590 | 0.020 |
Why?
| | Health Services Needs and Demand | 1 | 2011 | 279 | 0.020 |
Why?
| | HLA Antigens | 1 | 2010 | 227 | 0.020 |
Why?
| | New York | 1 | 2009 | 125 | 0.020 |
Why?
| | Equipment Failure | 1 | 2009 | 112 | 0.020 |
Why?
| | Blood Urea Nitrogen | 1 | 2008 | 52 | 0.020 |
Why?
| | Health Services Research | 1 | 2011 | 395 | 0.020 |
Why?
| | Brain Injuries | 1 | 1994 | 506 | 0.020 |
Why?
| | Fourier Analysis | 2 | 2001 | 41 | 0.020 |
Why?
| | In Vitro Techniques | 1 | 2010 | 1054 | 0.020 |
Why?
| | DDT | 1 | 1988 | 2 | 0.020 |
Why?
| | Polychlorinated Biphenyls | 1 | 1988 | 12 | 0.020 |
Why?
| | Tooth, Deciduous | 1 | 1988 | 19 | 0.020 |
Why?
| | Transfection | 1 | 2010 | 952 | 0.020 |
Why?
| | Anti-Arrhythmia Agents | 1 | 1989 | 137 | 0.020 |
Why?
| | Health Policy | 1 | 2011 | 390 | 0.020 |
Why?
| | Population Surveillance | 1 | 2011 | 491 | 0.020 |
Why?
| | Preoperative Care | 1 | 2010 | 376 | 0.020 |
Why?
| | Hyperlipidemias | 1 | 2008 | 121 | 0.020 |
Why?
| | Michigan | 2 | 1985 | 135 | 0.020 |
Why?
| | Capsules | 1 | 2007 | 43 | 0.020 |
Why?
| | HLA-DRB1 Chains | 2 | 1997 | 111 | 0.020 |
Why?
| | Lithotripsy | 1 | 2007 | 49 | 0.020 |
Why?
| | Placebos | 1 | 2007 | 192 | 0.020 |
Why?
| | Phytotherapy | 1 | 2007 | 76 | 0.020 |
Why?
| | Public Health | 1 | 2011 | 560 | 0.020 |
Why?
| | Metabolic Diseases | 1 | 2007 | 114 | 0.010 |
Why?
| | Angiography | 2 | 2000 | 206 | 0.010 |
Why?
| | Rodent Control | 1 | 1985 | 2 | 0.010 |
Why?
| | Leptospirosis | 1 | 1985 | 8 | 0.010 |
Why?
| | Cardiomyopathies | 1 | 1989 | 333 | 0.010 |
Why?
| | Tooth Diseases | 1 | 1985 | 13 | 0.010 |
Why?
| | Cytokines | 1 | 2013 | 2093 | 0.010 |
Why?
| | Tooth Extraction | 1 | 1985 | 28 | 0.010 |
Why?
| | Benzofurans | 1 | 1985 | 25 | 0.010 |
Why?
| | Blood Gas Analysis | 2 | 2003 | 84 | 0.010 |
Why?
| | Amiodarone | 1 | 1985 | 31 | 0.010 |
Why?
| | Attitude to Health | 1 | 2008 | 436 | 0.010 |
Why?
| | Rural Population | 1 | 1990 | 638 | 0.010 |
Why?
| | Memory | 1 | 2007 | 296 | 0.010 |
Why?
| | Alleles | 2 | 1997 | 883 | 0.010 |
Why?
| | Inflammation | 1 | 1995 | 2893 | 0.010 |
Why?
| | Suburban Population | 1 | 1983 | 17 | 0.010 |
Why?
| | Hematocrit | 1 | 2004 | 107 | 0.010 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2008 | 2030 | 0.010 |
Why?
| | Serum Albumin | 1 | 2004 | 150 | 0.010 |
Why?
| | Self Concept | 1 | 2006 | 253 | 0.010 |
Why?
| | Occupational Diseases | 1 | 1985 | 161 | 0.010 |
Why?
| | Attention | 1 | 2007 | 458 | 0.010 |
Why?
| | Bronchopneumonia | 2 | 1973 | 6 | 0.010 |
Why?
| | Coronary Disease | 1 | 1985 | 369 | 0.010 |
Why?
| | Learning | 1 | 2007 | 447 | 0.010 |
Why?
| | Cell Line, Tumor | 1 | 2010 | 3609 | 0.010 |
Why?
| | Delayed-Action Preparations | 1 | 2003 | 182 | 0.010 |
Why?
| | Heptavalent Pneumococcal Conjugate Vaccine | 1 | 2002 | 13 | 0.010 |
Why?
| | Wounds and Injuries | 1 | 2010 | 949 | 0.010 |
Why?
| | T-Lymphocytes | 1 | 2010 | 2041 | 0.010 |
Why?
| | Technetium | 1 | 2001 | 10 | 0.010 |
Why?
| | Likelihood Functions | 1 | 2001 | 140 | 0.010 |
Why?
| | Glucocorticoids | 1 | 2004 | 539 | 0.010 |
Why?
| | Ifosfamide | 1 | 1999 | 38 | 0.010 |
Why?
| | Death, Sudden, Cardiac | 1 | 2001 | 196 | 0.010 |
Why?
| | Granulocyte Colony-Stimulating Factor | 1 | 1999 | 89 | 0.010 |
Why?
| | Etoposide | 1 | 1999 | 166 | 0.010 |
Why?
| | Carboplatin | 1 | 1999 | 160 | 0.010 |
Why?
| | Collagen | 2 | 1991 | 467 | 0.010 |
Why?
| | Combined Modality Therapy | 2 | 1994 | 1261 | 0.010 |
Why?
| | Cause of Death | 1 | 2000 | 461 | 0.010 |
Why?
| | Stroke Volume | 1 | 2001 | 617 | 0.010 |
Why?
| | Disease-Free Survival | 1 | 1999 | 767 | 0.010 |
Why?
| | HLA-DQ beta-Chains | 1 | 1997 | 59 | 0.010 |
Why?
| | Histocompatibility Testing | 1 | 1997 | 121 | 0.010 |
Why?
| | Prevalence | 1 | 2004 | 2819 | 0.010 |
Why?
| | Animals, Zoo | 1 | 1997 | 15 | 0.010 |
Why?
| | Hylobates | 1 | 1997 | 8 | 0.010 |
Why?
| | Pongo pygmaeus | 1 | 1997 | 7 | 0.010 |
Why?
| | Gorilla gorilla | 1 | 1997 | 18 | 0.010 |
Why?
| | Ileum | 1 | 1998 | 111 | 0.010 |
Why?
| | HLA-DP beta-Chains | 1 | 1997 | 90 | 0.010 |
Why?
| | Linkage Disequilibrium | 1 | 1997 | 248 | 0.010 |
Why?
| | Pan troglodytes | 1 | 1997 | 63 | 0.010 |
Why?
| | Leukocytes, Mononuclear | 1 | 1999 | 580 | 0.010 |
Why?
| | Amino Acid Substitution | 1 | 1997 | 304 | 0.010 |
Why?
| | Macaca mulatta | 1 | 1997 | 191 | 0.010 |
Why?
| | Gene Frequency | 1 | 1997 | 483 | 0.010 |
Why?
| | Hypoxia | 3 | 1973 | 1199 | 0.010 |
Why?
| | Haplotypes | 1 | 1997 | 490 | 0.010 |
Why?
| | Species Specificity | 1 | 1997 | 573 | 0.010 |
Why?
| | Disease Susceptibility | 1 | 1997 | 351 | 0.010 |
Why?
| | Electric Impedance | 1 | 1996 | 113 | 0.010 |
Why?
| | Heart Conduction System | 2 | 1989 | 92 | 0.010 |
Why?
| | Stem Cells | 1 | 1999 | 622 | 0.010 |
Why?
| | Dental Pulp Test | 1 | 1974 | 1 | 0.010 |
Why?
| | Alveolar Process | 1 | 1974 | 6 | 0.010 |
Why?
| | Tooth Mobility | 1 | 1974 | 5 | 0.010 |
Why?
| | Erythrocytes | 1 | 2001 | 757 | 0.010 |
Why?
| | Signal Processing, Computer-Assisted | 1 | 1996 | 153 | 0.010 |
Why?
| | Cell Movement | 1 | 1999 | 973 | 0.010 |
Why?
| | Polymorphism, Genetic | 1 | 1997 | 618 | 0.010 |
Why?
| | Health Behavior | 1 | 2000 | 794 | 0.010 |
Why?
| | Explosions | 1 | 1994 | 15 | 0.010 |
Why?
| | Accidents, Occupational | 1 | 1994 | 14 | 0.010 |
Why?
| | History, 19th Century | 1 | 1994 | 61 | 0.010 |
Why?
| | Sequence Analysis, DNA | 1 | 1997 | 828 | 0.010 |
Why?
| | Equipment Design | 1 | 1996 | 534 | 0.010 |
Why?
| | Penis | 1 | 1993 | 34 | 0.010 |
Why?
| | New York City | 1 | 1993 | 89 | 0.010 |
Why?
| | Temperature | 1 | 1996 | 681 | 0.010 |
Why?
| | Nerve Endings | 1 | 1972 | 4 | 0.010 |
Why?
| | Rib Fractures | 1 | 1972 | 33 | 0.010 |
Why?
| | Baltimore | 1 | 1991 | 67 | 0.010 |
Why?
| | Mandibular Condyle | 1 | 1991 | 5 | 0.010 |
Why?
| | Connective Tissue | 1 | 1991 | 39 | 0.010 |
Why?
| | Microscopy, Electron | 1 | 1972 | 415 | 0.010 |
Why?
| | CD4 Antigens | 1 | 1991 | 144 | 0.010 |
Why?
| | Temporal Bone | 1 | 1991 | 42 | 0.010 |
Why?
| | Atrophy | 1 | 1991 | 199 | 0.010 |
Why?
| | Income | 1 | 1991 | 197 | 0.010 |
Why?
| | Nitroprusside | 1 | 1990 | 72 | 0.010 |
Why?
| | Chromatography, Affinity | 1 | 1990 | 88 | 0.010 |
Why?
| | Chromatography, Gel | 1 | 1990 | 129 | 0.010 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 1990 | 330 | 0.000 |
Why?
| | Solubility | 1 | 1990 | 239 | 0.000 |
Why?
| | Immunoblotting | 1 | 1990 | 307 | 0.000 |
Why?
| | Disease Progression | 1 | 1997 | 2871 | 0.000 |
Why?
| | Syncope | 1 | 1989 | 55 | 0.000 |
Why?
| | Skin Diseases | 1 | 1990 | 149 | 0.000 |
Why?
| | Cardiac Pacing, Artificial | 1 | 1989 | 82 | 0.000 |
Why?
| | Enzyme Activation | 1 | 1990 | 782 | 0.000 |
Why?
| | Calcinosis | 1 | 1990 | 235 | 0.000 |
Why?
| | Cattle | 1 | 1990 | 1004 | 0.000 |
Why?
| | Osteoporosis | 1 | 1990 | 245 | 0.000 |
Why?
| | Absenteeism | 1 | 1986 | 52 | 0.000 |
Why?
| | Psychotropic Drugs | 1 | 1986 | 76 | 0.000 |
Why?
| | Oral Surgical Procedures, Preprosthetic | 1 | 1985 | 1 | 0.000 |
Why?
| | Tooth Eruption | 1 | 1985 | 10 | 0.000 |
Why?
| | Malocclusion | 1 | 1985 | 22 | 0.000 |
Why?
| | Tooth Injuries | 1 | 1985 | 9 | 0.000 |
Why?
| | Periodontal Diseases | 1 | 1985 | 61 | 0.000 |
Why?
| | Asthma | 1 | 1996 | 1915 | 0.000 |
Why?
| | Heart Aneurysm | 1 | 1982 | 12 | 0.000 |
Why?
| | Ambulatory Care | 1 | 1986 | 592 | 0.000 |
Why?
| | Cryosurgery | 1 | 1982 | 47 | 0.000 |
Why?
| | Hypotension | 2 | 1972 | 127 | 0.000 |
Why?
| | Carbon Dioxide | 2 | 1973 | 242 | 0.000 |
Why?
| | Streptococcal Infections | 2 | 1973 | 160 | 0.000 |
Why?
| | Suicide | 1 | 1986 | 667 | 0.000 |
Why?
| | Respiration, Artificial | 2 | 1972 | 706 | 0.000 |
Why?
| | Rats | 1 | 1985 | 5609 | 0.000 |
Why?
| | Acid-Base Equilibrium | 1 | 1973 | 24 | 0.000 |
Why?
| | Neurologic Manifestations | 1 | 1972 | 3 | 0.000 |
Why?
| | Anuria | 1 | 1972 | 3 | 0.000 |
Why?
| | Drowning | 1 | 1972 | 6 | 0.000 |
Why?
| | Embolism, Fat | 1 | 1972 | 11 | 0.000 |
Why?
| | Tracheotomy | 1 | 1972 | 23 | 0.000 |
Why?
| | Cyanosis | 1 | 1972 | 16 | 0.000 |
Why?
| | Mitral Valve Stenosis | 1 | 1972 | 19 | 0.000 |
Why?
| | Positive-Pressure Respiration | 1 | 1973 | 111 | 0.000 |
Why?
| | Pneumococcal Infections | 1 | 1973 | 104 | 0.000 |
Why?
| | Anti-Bacterial Agents | 2 | 1973 | 1901 | 0.000 |
Why?
| | Blood Proteins | 1 | 1973 | 249 | 0.000 |
Why?
| | Shock | 1 | 1972 | 109 | 0.000 |
Why?
| | Heparin | 1 | 1972 | 250 | 0.000 |
Why?
| | Resuscitation | 1 | 1972 | 301 | 0.000 |
Why?
| | Influenza, Human | 1 | 1973 | 611 | 0.000 |
Why?
| | Pneumonia, Viral | 1 | 1972 | 385 | 0.000 |
Why?
| | Hemorrhage | 1 | 1972 | 799 | 0.000 |
Why?
| | Oxygen | 1 | 1972 | 1000 | 0.000 |
Why?
| | Alcoholism | 1 | 1972 | 814 | 0.000 |
Why?
|
|
Frank's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|